[Immunodepressive effect of L-asparaginase. II. Clinical and biological study in patients with chronic glomerulopathy].
D000328:Adult; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008213:Lymphocyte Activation; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011507:Proteinuria / Q000188:drug therapy; D012882:Skin Tests
D007166:Immunosuppressive Agents; D003165:Complement System Proteins; D001215:Asparaginase
Effet immunodépresseur de la L-asparaginase. II. Etude clinique et biologique chez des sujets atteints de glomérulopathie chronique.